Ashish Kamat, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Janssen Pharmaceutical
    Date added:
    Date updated:
    09/26/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    ProTara
    Date added:
    Date updated:
    09/26/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Seattle Genetics
    Date added:
    Date updated:
    09/26/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Biological Dynamics
    Date added:
    Date updated:
    09/26/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Asieris
    Date added:
    Date updated:
    09/26/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Abbott Molecular
    Date added:
    Date updated:
    09/26/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    BMS
    Date added:
    Date updated:
    09/26/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    MDxHealth
    Date added:
    Date updated:
    09/26/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Cepheid
    Date added:
    Date updated:
    09/26/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Pfizer
    Date added:
    Date updated:
    09/26/2025

Pages

Return to The Journal of Urology Vol. 210 (2023): November